BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhangu JS, Taghizadeh H, Braunschmid T, Bachleitner-hofmann T, Mannhalter C. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden. Surgical Oncology 2017;26:395-401. [DOI: 10.1016/j.suronc.2017.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Wei R, Liu S, Zhang S, Min L, Zhu S. Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers. Anal Cell Pathol (Amst) 2020;2020:6283796. [PMID: 32377504 DOI: 10.1155/2020/6283796] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
2 Vymetalkova V, Cervena K, Bartu L, Vodicka P. Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review. Int J Mol Sci 2018;19:E3356. [PMID: 30373199 DOI: 10.3390/ijms19113356] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
3 Shi W, Xu X, Huang R, Yu Q, Zhang P, Xie S, Zheng H, Lu R. Plasma C-MYC level manifesting as an indicator in progression of breast cancer. Biomark Med 2019;13:917-29. [PMID: 31144531 DOI: 10.2217/bmm-2019-0073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 Fettke H, Kwan EM, Azad AA. Cell-free DNA in cancer: current insights. Cell Oncol (Dordr) 2019;42:13-28. [PMID: 30367445 DOI: 10.1007/s13402-018-0413-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
5 Paramathas S, Guha T, Pugh TJ, Malkin D, Villani A. Considerations for the use of circulating tumor DNA sequencing as a screening tool in cancer predisposition syndromes. Pediatr Blood Cancer 2020;67:e28758. [PMID: 33047872 DOI: 10.1002/pbc.28758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Chand M, Keller DS, Mirnezami R, Bullock M, Bhangu A, Moran B, Tekkis PP, Brown G, Mirnezami A, Berho M. Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data. World J Gastrointest Oncol 2018; 10(7): 145-158 [PMID: 30079141 DOI: 10.4251/wjgo.v10.i7.145] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
7 Jiang H, Yu Q, Chen X, Zhang C, Shen J, Shen M, Yang Y, Wang B, Pan B, Guo W. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients. J Clin Lab Anal 2021;35:e24030. [PMID: 34591323 DOI: 10.1002/jcla.24030] [Reference Citation Analysis]
8 Yan YY, Guo QR, Wang FH, Adhikari R, Zhu ZY, Zhang HY, Zhou WM, Yu H, Li JQ, Zhang JY. Cell-Free DNA: Hope and Potential Application in Cancer. Front Cell Dev Biol 2021;9:639233. [PMID: 33693004 DOI: 10.3389/fcell.2021.639233] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Martínez-Sanchíz C, García-Olmo DC, Picazo-Martínez MG, Nam-Cha SY, Giménez-Bachs JM, Flores-Bautista AB, Díaz-Piqueras Á, Salinas-Sánchez AS. Diagnostic and prognostic value of the detection of hTERT mRNA in renal tumors. Urol Oncol 2019;37:749-57. [PMID: 30975552 DOI: 10.1016/j.urolonc.2019.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Mohamadzaheri M, Cheraghi H, Shirani D, Hatamkhani A. Relationship between plasma cell-free DNA changes and lysyl oxidase during the treatment and prognosis of canine transmissible venereal tumors. BMC Vet Res 2022;18:76. [PMID: 35189882 DOI: 10.1186/s12917-022-03173-z] [Reference Citation Analysis]
11 Arzuaga-mendez J, Prieto-fernández E, Lopez-lopez E, Martin-guerrero I, García-ruiz JC, García-orad A. Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review. Critical Reviews in Oncology/Hematology 2019;139:7-15. [DOI: 10.1016/j.critrevonc.2019.04.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Hao S, Ren M, Li D, Sui Y, Wang Q, Chen G, Li Z, Yang Q. Fisher linear discriminant analysis for classification and prediction of genomic susceptibility to stomach and colorectal cancers based on six STR loci in a northern Chinese Han population. PeerJ 2019;7:e7004. [PMID: 31179189 DOI: 10.7717/peerj.7004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Gabriel E, Bagaria SP. Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction. Front Oncol. 2018;8:297. [PMID: 30128304 DOI: 10.3389/fonc.2018.00297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
14 Pastor B, Abraham JD, Pisareva E, Sanchez C, Kudriavstev A, Tanos R, Mirandola A, Mihalovičová L, Pezzella V, Adenis A, Ychou M, Mazard T, Thierry AR. Association of neutrophil extracellular traps with the production of circulating DNA in patients with colorectal cancer. iScience 2022;25:103826. [PMID: 35198886 DOI: 10.1016/j.isci.2022.103826] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Reece M, Saluja H, Hollington P, Karapetis CS, Vatandoust S, Young GP, Symonds EL. The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer. Front Genet 2019;10:1118. [PMID: 31824558 DOI: 10.3389/fgene.2019.01118] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
16 Sugimachi K, Sakimura S, Kuramitsu S, Hirata H, Niida A, Iguchi T, Eguchi H, Masuda T, Morita M, Toh Y, Maehara Y, Suzuki Y, Mimori K. Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy. Br J Cancer 2018;119:419-23. [PMID: 30072744 DOI: 10.1038/s41416-018-0208-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]